0
₹0 0
Nextgen Biotech

Call us:

menu

Cytax 260mg - Paclitaxel Injuction

  • Home
  • Cytax 260mg - Paclitaxel Injuction

Cytax 260mg - Paclitaxel Injuction

Cytax 260mg is a chemotherapy injection containing Paclitaxel, widely used for the treatment of various cancers including breast, ovarian, lung, and pancreatic cancer. It works by inhibiting the division of cancer cells, thereby slowing or stopping tumor growth.

Select the packing Size:

Choose Quantity:

-
+
+ Add To Cart
Add to wishlist
Share
Description Product Details
General Information:
Generic Name: Paclitaxel
Brand Name: Cytax 260mg
Packing: Single-use vial
Strength: 260 mg/43.4 mL (6 mg/mL)
Manufacturer: [Insert Manufacturer Name]
Form: Injectable concentrate
Category: Antineoplastic (Taxane derivative)
Product Introduction:
Cytax 260mg is an anti-cancer medication from the taxane class. It contains Paclitaxel, a natural product derived from the Pacific yew tree. It is used either alone or in combination with other chemotherapy agents. This injection is administered intravenously under the supervision of an oncologist.
Uses:
Cytax 260mg is indicated for the treatment of:
  1. Metastatic breast cancer
  2. Ovarian cancer (initial and recurrent)
  3. Non-small cell lung cancer (NSCLC)
  4. Pancreatic cancer (as part of combination therapy)
  5. Kaposi’s sarcoma in AIDS patients
  6. Other solid tumors as determined by a medical oncologist
Storage Instructions:
  1. Store at 25°C (may range between 15°C to 30°C)
  2. Do not freeze
  3. Protect from light and moisture
  4. After dilution, use within the recommended time as per hospital protocol
  5. Keep away from children
How It Works (Mechanism of Action):
Paclitaxel stabilizes microtubules in the cell and prevents their breakdown during cell division (mitosis). This inhibits the normal process of mitosis, causing cell death in rapidly dividing cancer cells.
Side Effects:
Common side effects:
  1. Hair loss (alopecia)
  2. Nausea and vomiting
  3. Diarrhea
  4. Peripheral neuropathy (numbness, tingling)
  5. Fatigue
  6. Low white blood cell counts (neutropenia)
Severe side effects:
  1. Allergic or hypersensitivity reactions
  2. Severe neutropenia or anemia
  3. Heart rhythm disturbances
  4. Liver function abnormalities
  5. Infections due to immunosuppression
Dosage (Typical Recommended Dose):
  1. The typical dosage is 175 mg/m² every 3 weeks or 80 mg/m² weekly, depending on the cancer type and treatment protocol
  2. Cytax 260mg is dosed based on body surface area (BSA)
  3. Only a qualified oncologist can determine the exact dosage per patient
Method of Administration:
  1. Administered via intravenous infusion over 3 hours
  2. Requires pre-medication with corticosteroids, antihistamines, and H2 blockers to prevent hypersensitivity reactions
  3. Should be diluted in a suitable IV fluid (e.g., 5% dextrose or normal saline)
  4. Given in a hospital or clinical oncology setup under professional supervision
Precautions:
  1. Patients should be pre-medicated to reduce allergy risk
  2. Monitor blood counts, liver and kidney functions regularly
  3. Not recommended during pregnancy or breastfeeding
  4. Use effective contraception during and after treatment
  5. Avoid crowds or sick individuals due to infection risk
Drug Interactions:
  1. Interacts with cisplatin, increasing risk of neurotoxicity and myelosuppression
  2. May affect drugs metabolized by CYP3A4 and CYP2C8 enzymes
  3. Use caution with live vaccines
  4. Inform your doctor of all current medications and herbal supplements
Allergies:
  1. Contraindicated in patients with a history of hypersensitivity to Paclitaxel or polyoxyethylated castor oil (Cremophor EL)
  2. Watch for signs of allergy: rash, itching, swelling, dizziness, or breathing issues
  3. Emergency care is required for anaphylaxis
Overdose Information:
  1. Overdose may lead to severe bone marrow suppression, neuropathy, and mucositis
  2. There is no specific antidote
  3. Management is symptomatic and supportive, with intensive monitoring
Missed Dose Instructions:
  1. If a scheduled dose is missed, consult your oncologist immediately
  2. Do not attempt to take a missed dose without medical supervision
  3. The doctor may adjust your schedule based on clinical condition
Additional Notes:
  1. Hair loss is common but temporary
  2. Avoid alcohol and grapefruit juice during treatment
  3. Report fever, unusual bleeding, bruising, or signs of infection promptly
  4. Periodic monitoring is essential for safe and effective therapy
  5. The treatment regimen and cycles depend on the cancer type and patient response

In The Same Category

Cart